Miraca Holdings Inc. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015; Provides Earnings Guidance for the Second Quarter Ending September 30, 2015 and Fiscal Year Ending March 31, 2016; Provides Dividend Guidance for the Second Quarter Ending September 30, 2015 and Fiscal Year Ending March 31, 2016
July 30, 2015
Share
Miraca Holdings Inc. announced consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported net sales of ¥52,734 million, operating income of ¥6,653 million, ordinary income of ¥6,368 million, income before income taxes and minority interests of ¥6,369 million, profit attributable to the owners of the parent of ¥3,969 million or ¥69.59 per diluted share, net cash provided by operating activities of ¥3,642 million, purchase of property, plant and equipment of ¥1,485 million, purchase of intangible assets was ¥1,881 million compared to the net sales of ¥51,208 million, operating income of ¥7,138 million, ordinary income of ¥6,819 million, income before income taxes and minority interests of ¥5,904 million, net income of ¥3,258 million or ¥55.41 per diluted share, net cash provided by operating activities of ¥1,583 million, purchase of property, plant and equipment of ¥1,305 million, purchase of intangible assets of ¥1,532 million for the same quarter a year ago. Net assets per share were ¥3,092.79.
For the six months ending September 30, 2015, the company expected net sales of ¥105,300 million, operating income of ¥14,000 million, ordinary income of ¥13,350 million, profit attributable to the owners of the parent of ¥7,450 million and net income per share of ¥130.84.
For the fiscal year ending March 31, 2016, the company expected net sales of ¥210,000 million, operating income of ¥27,700 million, ordinary income of ¥26,950 million, profit attributable to the owners of the parent of ¥16,900 million and net income per share of ¥296.80.
For the fiscal year ending March 31, 2016, the company expects to pay second quarter and year end dividend of ¥55.00 per share compared to the dividend of ¥46.00 per share paid in the previous year.
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
Miraca Holdings Inc. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015; Provides Earnings Guidance for the Second Quarter Ending September 30, 2015 and Fiscal Year Ending March 31, 2016; Provides Dividend Guidance for the Second Quarter Ending September 30, 2015 and Fiscal Year Ending March 31, 2016